Behavidence Israel
AI-based digital phenotyping to measure and monitor mental health from smartphone behavior.
Company Overview
Snapshot
Founded in February 2025, Behavidence Israel operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its AI-based digital phenotyping technology for mental health measurement.
Business overview
Behavidence Israel develops an AI-based digital phenotyping platform designed to measure and monitor mental health through passive smartphone usage. Its core technology generates daily behavioral scores to support screening and remote monitoring for conditions such as depression, anxiety, stress, and ADHD. The platform serves healthcare providers, insurers, researchers, and organizations requiring ongoing, low-burden mental health tracking, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring.
Log in to access full profile ›Company Intelligence Q&A
- What is Behavidence Israel's primary focus?
- Behavidence Israel focuses on AI-based digital phenotyping to measure and monitor mental health using smartphone behavior patterns.
- When was Behavidence Israel founded?
- Behavidence Israel was founded in February 2025.
- What conditions does Behavidence Israel's platform help monitor?
- The platform supports screening and remote monitoring for conditions including depression, anxiety, stress, and ADHD.
- How does Behavidence Israel's technology gather data?
- Behavidence Israel's technology generates daily behavioral scores from passive smartphone usage patterns, ensuring privacy-focused data handling.
- Which industries or entities can utilize Behavidence Israel's solution?
- The solution is positioned for use by healthcare providers, insurers, researchers, and organizations that require ongoing mental health tracking.